Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 9/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Artenimol SCHEMBL19937859 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL14552892 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL16404831 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL19236349 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL19600821 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL18421801 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL23843510 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL2132158 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL21707299 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 | |
| Artenimol SCHEMBL21707301 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4657 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094963-A | Cardioprotective lipids and methods of use | — | 2026-05-26 | — | — | CN | claimed |
| EP-4744680-A1 | TARGETED CHEMICAL DRUG AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE OF TARGETED CHEMICAL DRUG | Bai Yao Zhi Da (Beijing) Nanobio Technology Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122057017-A | Phase-change material microsphere with energy storage enhanced photothermal therapy function, preparation method and application | 西安交通大学医学院第一附属医院 | 2026-05-19 | — | — | CN | claimed |
| US-20260130918-A1 | TRANSCRIPTION FACTOR PFAP2-O5 INHIBITOR FOR PLASMODIUM FALCIPARUM, PHARMACEUTICAL COMPOSITION, AND DRUG FOR TREATING MALARIA RESISTANT TO ARTEMISININ AND ANALOG THEREOF | TONGJI UNIVERSITY (CN) | 2026-05-14 | — | — | US | claimed |
| CN-116531317-B | Antitumor hydrogel based on hunger therapy and preparation and application thereof | 上海市浦东医院（复旦大学附属浦东医院） | 2026-05-12 | — | — | CN | claimed |
| CN-122005541-A | Use of dihydroartemisinin in preparation of medicine for preventing, delaying and/or treating ovarian aging and related diseases thereof | 北京大学第三医院（北京大学第三临床医学院） | 2026-05-12 | — | — | CN | claimed |
| US-20260124307-A1 | APPLICATION OF DHA@ZIF-8 IN TREATMENT OF EXPERIMENTAL CEREBRAL MALARIA | HUBEI UNIVERSITY OF MEDICINE (CN) | 2026-05-07 | — | — | US | claimed |
| EP-4735431-A2 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260115233-A1 | APPLICATION OF AKKERMANSIA MUCINIPHILA IN AMELIORATION AND TREATMENT OF CEREBRAL MALARIA CAUSED BY PLASMODIUM BERGHEI | HUBEI UNIVERSITY OF MEDICINE (CN) | 2026-04-30 | — | — | US | claimed |
| WO-1996034602-A1 | METHODS OF INHIBITION OR KILLING OF CANCER CELLS | UNIVERSITY OF WASHINGTON (US) | 1996-11-07 | — | — | WO | claimed |
| WO-1995034262-A1 | TRANSDERMAL TREATMENT OF MALARIA | DEPARTMENT OF THE ARMY, US GOVERNMENT (US) | 1995-12-21 | — | — | WO | claimed |
| US-5219880-A | Treatment of viral tumors and hemorrhoids with artemisinin and derivatives | DERMATOLOGIC RESEARCH CORPORATION (US) | 1993-06-15 | — | — | US | claimed |
| EP-0535719-A2 | Treatment of hemorrhoids with artemisinin and derivates | DERMATOLOGIC RESEARCH CORPORATION (US) | 1993-04-07 | — | — | EP | claimed |
| US-5171676-A | Hydroxylation with Beauveria sulfurescens, while preserving peroxide linkage; antimalarial agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-12-15 | — | — | US | claimed |
| US-5057501-A | Methods for treatment of papulosquamous and eczematous diseases | DERMATOLOGIC RESEARCH CORPORATION (US) | 1991-10-15 | — | — | US | claimed |
| EP-0428773-A1 | Treatment of skin diseases with artemisinin and derivatives | DERMATOLOGIC RESEARCH CORPORATION (US) | 1991-05-29 | — | — | EP | claimed |
| US-4978676-A | Treatment of skin diseases with artemisinin and derivatives | CELLEGY PHARMACEUTICALS, INC. | 1990-12-18 | — | — | US | claimed |
| WO-1990010442-A1 | TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME | THORNFELDT CARL R (US) | 1990-09-20 | — | — | WO | claimed |
| US-4816478-A | Treatment of acquired immunodeficiency syndrome | CELLEGY PHARMACEUTICALS, INC. | 1989-03-28 | — | — | US | claimed |